MCTC Expands R&D Program to Include Producing Polymeric Nanoparticles of Valuable, Hard-to-Obtain Cannabinoids
20 nov. 2019 07h30 HE
|
MCTC Holdings Inc. (d/b/a Cannabis Global)
LOS ANGELES, Nov. 20, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – MCTC Holdings Inc. (OTC: MCTC) today announces an expanded R&D program designed to produce polymeric nanoparticles of cannabinol...
Cannabis Science Set to Integrate Its Sponsored Research In Nigeria to Include Its U.S. Patent Number 9,763,991 for Compositions of Cannabinol (CBN) for Treatment of Various Neurological Conditions
25 févr. 2019 07h28 HE
|
Cannabis Science, Inc.
IRVINE, CA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Pre-Clinical Work and Animal Studies Underway, and Protocols for Clinical Studies Under Development via NEWMEDIAWIRE -- Cannabis Science, Inc....
Cannabis Science Confirms Receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and (PTSD)
29 oct. 2018 09h01 HE
|
Cannabis Science, Inc.
IRVINE, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...